LT - Kristalinė (R)-2-[[[3-metil-4-(2,2,2-trifluoretoksi)-2-piridinil]metil]sulfinil]-1H-benzimidazolo forma
EN - CRYSTALLINE FORM OF (R)-2-[[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZIMIDAZOLE
Legal status
Patent expired
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 401/12 |
(2006.01) |
|
|
A61K 31/44 |
(2006.01) |
|
|
A61P 1/04 |
(2006.01) |
European patent
(11) |
Number of the document |
1129088 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
00937235.0 |
|
Date of filing the European patent application |
2000-06-15 |
(97) |
Date of publication of the European application |
2001-09-05 |
(45) |
Date of publication and mention of the grant of the patent |
2008-04-02
|
(46) |
Date of publication of the claims translation |
2008-08-25
|
PCT application
(86) |
Number |
PCT/JP2000/003880 |
|
Date |
2000-06-15 |
PCT application publication
(87) |
Number |
WO 2000/078745 |
|
Date |
2000-12-28 |
Priority applications
(30) |
Number |
Date |
Country code |
|
17150999 |
1999-06-17
|
JP |
Inventors
(72) |
FUJISHIMA, Akira, JP
AOKI, Isao, JP
KAMIYAMA, Keiji, JP
|
Grantee
(73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka,
JP
|
Attorney or representative
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
(54) |
Kristalinė (R)-2-[[[3-metil-4-(2,2,2-trifluoretoksi)-2-piridinil]metil]sulfinil]-1H-benzimidazolo forma |
|
CRYSTALLINE FORM OF (R)-2-[[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZIMIDAZOLE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2019-05-31 |
20 |
347.00
EUR
|